ACRO Biomedical Co., Ltd. (TPEX: 6748)
Health Care · Biotechnology · TW
NT$194.50
-8.69% today · +175.9% 1Y
ACRO Biomedical Co., Ltd. (TPEX: 6748) operates in the Biotechnology industry within the Health Care sector. The company is valued at $429.72M and employs 42 people.
Over the last twelve months the share price has gained 175.9%, trading between 57.30 and 310.00.
Tweenvest scores ACRO Biomedical Co., Ltd. across four factors: quality 56/100, value 75/100. Its strongest factor is value.
6748 price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $429.72M
- Revenue (TTM)
- $1.66M
- P/E
- —
- EPS
- -1.19
- Dividend yield
- —
- Beta (5Y)
- 0.19
- 52-week high
- NT$310.00
- 52-week low
- NT$57.30
- Avg volume (3M)
- —
- Shares outstanding
- 71.68M
- Employees
- 42
- Next earnings
- —
About ACRO Biomedical Co., Ltd.
ACRO Biomedical Co., Ltd. is dedicated to the creation and manufacturing of biomaterial-based medical devices, specifically designed for applications in human tissue engineering and regenerative medicine. This company was established on June 26, 2014, and operates primarily from its headquarters in Kaohsiung, Taiwan.
- ISIN
- TW0006748007
- Founded
- 2014
- Listed since
- Jul 27, 2021
- Exchange
- Taipei Exchange
- Currency
- TWD
Other Biotechnology companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Egetis Therapeutics AB (publ)OM: EGTX | $433.80M | Skr9.24 | -6.95% |
| Eikon Therapeutics, Inc.NasdaqGS: EIKN | $433.32M | $8.00 | -2.20% |
| Allogene Therapeutics, Inc.NasdaqGS: ALLO | $431.86M | $1.25 | -6.02% |
| Assembly Biosciences, Inc.NasdaqGS: ASMB | $431.44M | $21.19 | +5.11% |
| Prothena Corporation plcNasdaqGS: PRTA | $428.66M | $8.35 | -5.54% |
| MapLight Therapeutics, Inc.NasdaqGS: MPLT | $427.93M | $7.70 | -12.80% |
| Ovid Therapeutics Inc.NasdaqCM: OVID | $421.84M | $2.16 | -8.86% |
| YD Bio LimitedNasdaqGM: YDES | $419.32M | $5.92 | -12.04% |
Figures last refreshed Oct 18, 2026.